Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Higher hair levels of zinc and chromium were linked to less cognitive decline in very old people.

Higher early lead exposure is linked to delayed puberty in girls.

High levels of cortisol in hair are linked to a greater risk of brain aneurysm rupture.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

People with androgenetic alopecia have a higher risk of heart disease.

No single treatment is clearly effective for central serous chorioretinopathy.

New method finds genetic links between Type 2 Diabetes and Prostate Cancer not seen before.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Vitiligo is underreported in medical claims and is linked to certain skin types and autoimmune diseases.

One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Caffeine may benefit skin and hair health but more research is needed to confirm its effectiveness in dermatology.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

Vasodilators may worsen abdominal aortic aneurysm.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

PCOS increases the risk of heart disease and type 2 diabetes in women.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Selenium is essential for health, but too much or too little can cause problems; blood selenium levels are a good measure of intake.

Men with severe balding have a higher risk of getting very sick from COVID-19.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.